BetterLife Pharma (BETRF) Other Non-Current Liabilities (2011 - 2026)

BetterLife Pharma's Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $98688.3 for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities fell 50.13% year-over-year to $98688.3; the TTM figure through Apr 2026 stood at $98688.3 (down 50.13% YoY), while the FY2026 annual figure was $82874.9, down 62.4% from the prior year.
• Other Non-Current Liabilities for Q2 2026 stood at $98688.3, up from $82874.9 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $4.3 million in Q2 2022, with the low at $278.9 in Q1 2022.
• The 5-year median for Other Non-Current Liabilities is $193090.0 (2023), against an average of $420023.6.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities jumped 11301.92% in 2022, then sank 95.07% in 2023.
• BetterLife Pharma's Other Non-Current Liabilities stood at $18022.1 in 2022, then soared by 944.69% to $188274.8 in 2023, then slipped by 7.94% to $173328.3 in 2024, then fell by 9.16% to $157456.4 in 2025, then tumbled by 37.32% to $98688.3 in 2026.
• Business Quant data shows BETRF's Other Non-Current Liabilities at $98688.3 in Q2 2026, $82874.9 in Q1 2026, and $157456.4 in Q3 2025.